LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

Search

MannKind Corp

Închisă

SectorSănătate

4.59 2

Rezumat

Modificarea prețului

24h

Curent

Minim

4.5

Maxim

4.61

Indicatori cheie

By Trading Economics

Venit

-12M

668K

Vânzări

-1.8M

77M

P/E

Medie Sector

35.455

35.724

Marjă de profit

0.873

Angajați

403

EBITDA

-17M

9.7M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+105.45% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

5.2M

1.2B

Deschiderea anterioară

2.59

Închiderea anterioară

4.59

Sentimentul știrilor

By Acuity

15%

85%

22 / 372 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

MannKind Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 aug. 2025, 18:43 UTC

Principalele dinamici ale pieței

Privia Health Shares Advance on Outlook Bump From Medicare Savings

29 aug. 2025, 15:07 UTC

Achiziții, Fuziuni, Preluări

Strathcona Resources to Increase Minority Stake in MEG Energy, Vote Against Cenovus Buyout Plan

29 aug. 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Auto & Transport Roundup: Market Talk

29 aug. 2025, 20:24 UTC

Câștiguri

Earnings Season Highlights on Tariffs, Consumer Spending, and More -- Barrons.com

29 aug. 2025, 20:17 UTC

Câștiguri

These Stocks Moved the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 aug. 2025, 19:18 UTC

Market Talk

Oil Futures End Week With Modest Gains -- Market Talk

29 aug. 2025, 18:59 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

29 aug. 2025, 18:36 UTC

Câștiguri

These Were the Best & Worst S&P 500 Stocks in August -- Barrons.com

29 aug. 2025, 18:26 UTC

Câștiguri

What the Stock Market Learned About Earnings and Consumers This Summer -- Barrons.com

29 aug. 2025, 17:48 UTC

Market Talk

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

29 aug. 2025, 17:10 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Regulator Firing Clears Path for Union Pacific-Norfolk Southern Deal -- Market Talk

29 aug. 2025, 16:57 UTC

Câștiguri

These Stocks Are Moving the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 aug. 2025, 16:30 UTC

Achiziții, Fuziuni, Preluări

Celsius Stock Is Spiking After PepsiCo Increases Stake -- Barrons.com

29 aug. 2025, 16:28 UTC

Achiziții, Fuziuni, Preluări

BBVA: Adjustment Intended to Maintain Equivalent Economic Terms of Offer Following Dividend Payments by Sabadell

29 aug. 2025, 16:27 UTC

Achiziții, Fuziuni, Preluări

BBVA: Adjustment Outlined in Announcement on May 9, 2024

29 aug. 2025, 16:26 UTC

Achiziții, Fuziuni, Preluări

BBVA Now Offering 1 Newly Issued Ordinary BBVA Share and EUR0.70 in Cash for Every 5.5483 Ordinary Shares of Sabadell

29 aug. 2025, 16:25 UTC

Achiziții, Fuziuni, Preluări

BBVA: Adjustment Factors in Interim Dividend Paid by Sabadell to Its Shareholders

29 aug. 2025, 16:24 UTC

Achiziții, Fuziuni, Preluări

BBVA Adjusts Offer for Banco de Sabadell

29 aug. 2025, 16:23 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Strathcona's Power Play in MEG Energy Jeopardizes Cenovus Deal -- Market Talk

29 aug. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29 aug. 2025, 16:06 UTC

Market Talk

Gold Futures Gain as U.S. Inflation Data Boost Rate Cut Hopes -- Market Talk

29 aug. 2025, 15:12 UTC

Market Talk
Câștiguri

Best Buy Surprise Comp Growth Potentially Driven by Switch 2 -- Market Talk

29 aug. 2025, 15:09 UTC

Câștiguri

Small-Cap Stocks Are Rallying Again. This Time It's Real. -- Barrons.com

29 aug. 2025, 15:01 UTC

Market Talk

Canadian Economy Expected to Slow But Grow in 2H -- Market Talk

29 aug. 2025, 14:49 UTC

Câștiguri

These Stocks Are Moving the Most Today: Marvell, Dell, Nvidia, Alibaba, Affirm, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 aug. 2025, 14:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29 aug. 2025, 14:49 UTC

Market Talk

Canada May Avoid Contraction in 3Q, But Is Expected to Struggle -- Market Talk

29 aug. 2025, 14:48 UTC

Câștiguri

Marvell Stock Tumbles. Why the AI Chip Player Keeps Disappointing the Market. -- Barrons.com

29 aug. 2025, 14:43 UTC

Market Talk

Rise in Canadian Household Spending May Not Worry Central Bank -- Market Talk

29 aug. 2025, 14:38 UTC

Market Talk

With Canada's Economy Soft, Central Bank Easing Looks Likely -- Market Talk

Comparație

Modificare preț

MannKind Corp Așteptări

Obiectiv de preț

By TipRanks

105.45% sus

Prognoză pe 12 luni

Medie 9.43 USD  105.45%

Maxim 12 USD

Minim 7 USD

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMannKind Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

7 ratings

7

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

4.079 / 4.323Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

22 / 372 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.